Skip to main content

1 Result(s)

within M. Rihm Remove this filter

and

  1. No Access

    Article

    Safety of the novel atrial-selective K+-channel blocker AVE0118 in experimental heart failure

    Congestive heart failure (CHF) is often associated with atrial fibrillation. The safety of many antiarrhythmic drugs in CHF is limited by proarrhythmic effects. We aimed to assess the safety of a novel atrial-...

    H.-J. Schneider, O. Husser, M. Rihm… in Naunyn-Schmiedeberg's Archives of Pharmaco… (2009)